BPCE
Bank Pictet & Cie (Europe) Portfolio holdings
AUM
$4.68B
1-Year Return
16.47%
This Quarter Return
+11.01%
1 Year Return
+16.47%
3 Year Return
+101.24%
5 Year Return
+155.05%
10 Year Return
+381.72%
AUM
$2.93B
AUM Growth
+$235M
(+8.7%)
Cap. Flow
-$11.6M
Cap. Flow
% of AUM
-0.4%
Top 10 Holdings %
Top 10 Hldgs %
44.67%
Holding
186
New
18
Increased
73
Reduced
52
Closed
6
Top Buys
| 1 |
Thermo Fisher Scientific
TMO
|
+$16.6M |
| 2 |
Air Products & Chemicals
APD
|
+$15.6M |
| 3 |
EOG Resources
EOG
|
+$14.3M |
| 4 |
Amazon
AMZN
|
+$8.82M |
| 5 |
Mastercard
MA
|
+$8.22M |
Top Sells
| 1 |
Chevron
CVX
|
+$17M |
| 2 |
Johnson & Johnson
JNJ
|
+$16.1M |
| 3 |
Visa
V
|
+$15.3M |
| 4 |
Fidelity National Information Services
FIS
|
+$11.7M |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
+$10.4M |
Sector Composition
| 1 | Healthcare | 24.57% |
| 2 | Technology | 21.52% |
| 3 | Consumer Discretionary | 14.33% |
| 4 | Communication Services | 13.93% |
| 5 | Financials | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Trane Technologies
TT
$89.2B
| $609K | 0.02% |
3,013
+459
| +18% | +$92.8K |
|
127
10x Genomics
TXG
$1.57B
| $567K | 0.02% |
3,806
+467
| +14% | +$69.6K |
|
128
iShares Core MSCI Europe ETF
IEUR
$6.92B
| $550K | 0.02% |
9,465
-700
| -7% | -$40.7K |
|
129
Netflix
NFLX
$505B
| $530K | 0.02% |
880
-165
| -16% | -$99.4K |
|
130
Workday
WDAY
$59.6B
| $508K | 0.02% |
1,858
+360
| +24% | +$98.4K |
|
131
Pacific Biosciences
PACB
$351M
| $499K | 0.02% |
24,393
+9,052
| +59% | +$185K |
|
132
Arrowhead Research
ARWR
$4.11B
| $490K | 0.02% |
7,395
+952
| +15% | +$63.1K |
|
133
Iovance Biotherapeutics
IOVA
$821M
| $477K | 0.02% |
24,989
+2,927
| +13% | +$55.9K |
|
|
B
134
Barrick Mining Corporation
B
$49.5B
| $455K | 0.02% |
+23,931
| New | +$455K |
|
135
Insulet
PODD
$24.1B
| $449K | 0.02% |
1,686
-418
| -20% | -$111K |
|
136
SPDR S&P Biotech ETF
XBI
$5.43B
| $447K | 0.02% |
3,989
-91,085
| -96% | -$10.2M |
|
137
AbbVie
ABBV
$386B
| $437K | 0.01% |
3,230
| – | – |
|
138
Castle Biosciences
CSTL
$621M
| $415K | 0.01% |
9,689
+1,065
| +12% | +$45.6K |
|
139
iShares Core US Aggregate Bond ETF
AGG
$132B
| $407K | 0.01% |
3,572
-380
| -10% | -$43.3K |
|
140
Vanguard Short-Term Corporate Bond ETF
VCSH
$35.4B
| $393K | 0.01% |
4,832
| – | – |
|
141
Twist Bioscience
TWST
$1.53B
| $361K | 0.01% |
4,668
+2,134
| +84% | +$165K |
|
142
Lockheed Martin
LMT
$110B
| $355K | 0.01% |
1,000
| – | – |
|
143
DaVita
DVA
$9.52B
| $341K | 0.01% |
+3,000
| New | +$341K |
|
144
Perrigo
PRGO
$3.06B
| $337K | 0.01% |
8,650
| – | – |
|
|
RDS.A
145
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $317K | 0.01% |
+7,300
| New | +$317K |
|
146
CRISPR Therapeutics
CRSP
$5.12B
| $309K | 0.01% |
4,076
+532
| +15% | +$40.3K |
|
147
Apellis Pharmaceuticals
APLS
$3.14B
| $300K | 0.01% |
+6,335
| New | +$300K |
|
148
Oracle
ORCL
$821B
| $299K | 0.01% |
3,433
| – | – |
|
|
149
Chevron
CVX
$317B
| $297K | 0.01% |
2,529
-144,923
| -98% | -$17M |
|
150
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$30.8B
| $293K | 0.01% |
2,212
-440
| -17% | -$58.3K |
|